Neurofeedback and traumatic brain injury

A literature review

Geoffrey May, Randall Benson, Richard Balon, Nash Boutros

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

BACKGROUND: Neurofeedback is a form of biofeedback whereby a patient can learn to control measurements of brain activity such as those recorded by an electroencephalogram. It has been explored as a treatment for sequelae of traumatic brain injury, although the use of neurofeedback remains outside the realm of routine clinical practice. METHODS: Google Scholar™ was used to find 22 examples of primary research. Measures of symptom improvement, neuropsychological testing, and changes in subjects' quantitative electroencephalogram were included in the analysis. A single reviewer classified each study according to a rubric devised by 2 societies dedicated to neurofeedback research. RESULTS: All studies demonstrated positive findings, in that neurofeedback led to improvement in measures of impairment, whether subjective, objective, or both. However, placebo-controlled studies were lacking, some reports omitted important details, and study designs differed to the point where effect size could not be calculated quantitatively. CONCLUSIONS: Neurofeedback is a promising treatment that warrants double-blind, placebo-controlled studies to determine its potential role in the treatment of traumatic brain injury. Clinicians can advise that some patients report improvement in a wide range of neuropsychiatric symptoms after undergoing neurofeedback, although the treatment remains experimental, with no standard methodology.

Original languageEnglish (US)
Pages (from-to)289-296
Number of pages8
JournalAnnals of Clinical Psychiatry
Volume25
Issue number4
StatePublished - 2013

Fingerprint

Neurofeedback
Electroencephalography
Placebos
Therapeutics
Research
Traumatic Brain Injury
Brain

Keywords

  • Neurofeedback
  • Quantitative electroencephalogram
  • Traumatic brain injury

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

May, G., Benson, R., Balon, R., & Boutros, N. (2013). Neurofeedback and traumatic brain injury: A literature review. Annals of Clinical Psychiatry, 25(4), 289-296.

Neurofeedback and traumatic brain injury : A literature review. / May, Geoffrey; Benson, Randall; Balon, Richard; Boutros, Nash.

In: Annals of Clinical Psychiatry, Vol. 25, No. 4, 2013, p. 289-296.

Research output: Contribution to journalArticle

May, G, Benson, R, Balon, R & Boutros, N 2013, 'Neurofeedback and traumatic brain injury: A literature review', Annals of Clinical Psychiatry, vol. 25, no. 4, pp. 289-296.
May G, Benson R, Balon R, Boutros N. Neurofeedback and traumatic brain injury: A literature review. Annals of Clinical Psychiatry. 2013;25(4):289-296.
May, Geoffrey ; Benson, Randall ; Balon, Richard ; Boutros, Nash. / Neurofeedback and traumatic brain injury : A literature review. In: Annals of Clinical Psychiatry. 2013 ; Vol. 25, No. 4. pp. 289-296.
@article{17476c3959024e26b4d248da7fa6d4ff,
title = "Neurofeedback and traumatic brain injury: A literature review",
abstract = "BACKGROUND: Neurofeedback is a form of biofeedback whereby a patient can learn to control measurements of brain activity such as those recorded by an electroencephalogram. It has been explored as a treatment for sequelae of traumatic brain injury, although the use of neurofeedback remains outside the realm of routine clinical practice. METHODS: Google Scholar™ was used to find 22 examples of primary research. Measures of symptom improvement, neuropsychological testing, and changes in subjects' quantitative electroencephalogram were included in the analysis. A single reviewer classified each study according to a rubric devised by 2 societies dedicated to neurofeedback research. RESULTS: All studies demonstrated positive findings, in that neurofeedback led to improvement in measures of impairment, whether subjective, objective, or both. However, placebo-controlled studies were lacking, some reports omitted important details, and study designs differed to the point where effect size could not be calculated quantitatively. CONCLUSIONS: Neurofeedback is a promising treatment that warrants double-blind, placebo-controlled studies to determine its potential role in the treatment of traumatic brain injury. Clinicians can advise that some patients report improvement in a wide range of neuropsychiatric symptoms after undergoing neurofeedback, although the treatment remains experimental, with no standard methodology.",
keywords = "Neurofeedback, Quantitative electroencephalogram, Traumatic brain injury",
author = "Geoffrey May and Randall Benson and Richard Balon and Nash Boutros",
year = "2013",
language = "English (US)",
volume = "25",
pages = "289--296",
journal = "Annals of Clinical Psychiatry",
issn = "1040-1237",
publisher = "Dowden Health Media,Inc",
number = "4",

}

TY - JOUR

T1 - Neurofeedback and traumatic brain injury

T2 - A literature review

AU - May, Geoffrey

AU - Benson, Randall

AU - Balon, Richard

AU - Boutros, Nash

PY - 2013

Y1 - 2013

N2 - BACKGROUND: Neurofeedback is a form of biofeedback whereby a patient can learn to control measurements of brain activity such as those recorded by an electroencephalogram. It has been explored as a treatment for sequelae of traumatic brain injury, although the use of neurofeedback remains outside the realm of routine clinical practice. METHODS: Google Scholar™ was used to find 22 examples of primary research. Measures of symptom improvement, neuropsychological testing, and changes in subjects' quantitative electroencephalogram were included in the analysis. A single reviewer classified each study according to a rubric devised by 2 societies dedicated to neurofeedback research. RESULTS: All studies demonstrated positive findings, in that neurofeedback led to improvement in measures of impairment, whether subjective, objective, or both. However, placebo-controlled studies were lacking, some reports omitted important details, and study designs differed to the point where effect size could not be calculated quantitatively. CONCLUSIONS: Neurofeedback is a promising treatment that warrants double-blind, placebo-controlled studies to determine its potential role in the treatment of traumatic brain injury. Clinicians can advise that some patients report improvement in a wide range of neuropsychiatric symptoms after undergoing neurofeedback, although the treatment remains experimental, with no standard methodology.

AB - BACKGROUND: Neurofeedback is a form of biofeedback whereby a patient can learn to control measurements of brain activity such as those recorded by an electroencephalogram. It has been explored as a treatment for sequelae of traumatic brain injury, although the use of neurofeedback remains outside the realm of routine clinical practice. METHODS: Google Scholar™ was used to find 22 examples of primary research. Measures of symptom improvement, neuropsychological testing, and changes in subjects' quantitative electroencephalogram were included in the analysis. A single reviewer classified each study according to a rubric devised by 2 societies dedicated to neurofeedback research. RESULTS: All studies demonstrated positive findings, in that neurofeedback led to improvement in measures of impairment, whether subjective, objective, or both. However, placebo-controlled studies were lacking, some reports omitted important details, and study designs differed to the point where effect size could not be calculated quantitatively. CONCLUSIONS: Neurofeedback is a promising treatment that warrants double-blind, placebo-controlled studies to determine its potential role in the treatment of traumatic brain injury. Clinicians can advise that some patients report improvement in a wide range of neuropsychiatric symptoms after undergoing neurofeedback, although the treatment remains experimental, with no standard methodology.

KW - Neurofeedback

KW - Quantitative electroencephalogram

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84902279716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902279716&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 289

EP - 296

JO - Annals of Clinical Psychiatry

JF - Annals of Clinical Psychiatry

SN - 1040-1237

IS - 4

ER -